Chugai’s FJ2 Project Won the 2023 Facility of the Year Awards from ISPE (International Society for Pharmaceutical Engineering)!
The FJ2 project of Chugai Pharma Manufacturing Co., Ltd. (“Chugai Pharma Manufacturing”), in which we were engaged, has been selected for the 2023 Facility of the Year Awards from the International Society for Pharmaceutical Engineering (ISPE).
The FJ2 project, for which we provided support services for conceptual design and engineering firm selection, has received the 2023 Facility of the Year Awards in the innovation category by the ISPE.
The FJ2 Project is to construct a low and mid-molecular API manufacturing facility (Building No.48) at the Fujieda Plant of Chugai Pharma Manufacturing. CM Plus was in charge of the UR (User Requirement) before the engineering firm’s assignment, the conceptual design as a quotation, support for the selection of the engineering firm, and quality control of the structure and welding during the construction phase.
CM Plus works closely with our clients to manage project plans and designs in the early stages of a project and provides support from a neutral standpoint without being tied to a specific company or technology in the quotations.
Please contact us if you have any questions or concerns about your facility construction project.
